Does Rallies show 13F holders for HLN?

Yes. Rallies tracks hedge fund and 13F ownership data for HLN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is HLN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HLN. It does not provide personalized investment advice.

HLN (Haleon plc American Depositary Shares (Each representing two Ordinary Shares)) Stock Analysis - Hedge Fund Holdings

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) is a publicly traded Healthcare sector company. As of May 20, 2026, HLN trades at $9.28 with a market cap of $40.62B and a P/E ratio of 0.00. HLN moved +0.92% today. Year to date, HLN is -8.21%; over the trailing twelve months it is -15.79%. Its 52-week range spans $8.71 to $11.42. Analyst consensus is buy with an average price target of $13.92. Rallies surfaces HLN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns HLN stock?

Hedge funds tracked by Rallies that own HLN include Harris Associates, Sculptor Capital, Bridgewater Associates, GQG Partners, and Chilton Investment. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Haleon plc American Depositary Shares (Each representing two Ordinary Shares).

HLN Key Metrics

Key financial metrics for HLN
Metric	Value
Price	$9.28
Market Cap	$40.62B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.13%
52-Week High	$11.42
52-Week Low	$8.71
Volume	7.49M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding HLN

Harris Associates holds 15.03M shares of HLN, changed +0.00% as of Mar 31, 2026.
Sculptor Capital holds 5.30M shares of HLN, changed -49.30% as of Mar 31, 2026.
Bridgewater Associates holds 189.56K shares of HLN, changed +0.00% as of Jun 30, 2024.
GQG Partners holds 27.73K shares of HLN, changed +0.00% as of Mar 31, 2024.
Chilton Investment holds 27.00K shares of HLN, changed +0.00% as of Dec 31, 2025.

Latest HLN News

Haleon among biggest fallers as FTSE plunges 102 points on Gulf tensions — May 5, 2026
Haleon Launches Reformulated Centrum 50+ with Clinically Shown Memory Benefits — May 4, 2026
Haleon slides as weak cold-and-flu season drags Q1 growth and respiratory sales — Apr 29, 2026
Haleon jumps as buyback activity and May dividend keep returns in focus — Apr 17, 2026
parodontax Launches Hyaluronic Acid Gum Protection Toothpaste and Mouthwash — Mar 12, 2026

HLN Analyst Consensus

1 analysts cover HLN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $13.92.

Common questions about HLN

Who owns HLN stock?: Hedge funds tracked by Rallies that own HLN include Harris Associates, Sculptor Capital, Bridgewater Associates, GQG Partners, and Chilton Investment. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Haleon plc American Depositary Shares (Each representing two Ordinary Shares).
Does Rallies show 13F holders for HLN?: Yes. Rallies tracks hedge fund and 13F ownership data for HLN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HLN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HLN. It does not provide personalized investment advice.